Experience

Quirk Hotel

• United States
• Hospitality
• 1 - 100 Employee

• Assistant Front Office Manager

  • Aug 2021 - Present



Eco Rooms, LLC

• Co-Founder

  • Jan 2020 - Aug 2021



Peachtree Presbyterian Preschool

• Teacher 2s and 3s

  • Sep 2013 - Dec 2018



Trial Runners

• United States
• Research
• 1 - 100 Employee

• Regional Monitor

  • Jan 2012 - Nov 2012

  ~Successfully monitored clinical trials in the following areas: ---Ophthalmology- Uveitis – Phase III study (45 Subjects, 15 Sites); Wet Age-Related Macular Degeneration - Phase I/IIa study (18 Subjects, 5 Sites) ---Metabolic- Thyroid Function – Phase II study (200 Subjects, 9 Sites) ~Conducted frequent site visits across the country, including pre-study, initiation, interim and closeout visits ~Negotiated contracts and budgets with clinical sites on behalf of Sponsors ~Successfully monitored clinical trials in the following areas: ---Ophthalmology- Uveitis – Phase III study (45 Subjects, 15 Sites); Wet Age-Related Macular Degeneration - Phase I/IIa study (18 Subjects, 5 Sites) ---Metabolic- Thyroid Function – Phase II study (200 Subjects, 9 Sites) ~Conducted frequent site visits across the country, including pre-study, initiation, interim and closeout visits ~Negotiated contracts and budgets with clinical sites on behalf of Sponsors



Iconic Therapeutics, Inc.

• Clinical Trial Monitor

  • Feb 2009 - Jan 2012

  ~Received clinical trial monitor training from Trial Runners with a focus on Ophthalmology ~Monitored a successful 18 subject Phase I clinical trial for a novel therapeutic to treat Wet Age-Related Macular Degeneration (Wet AMD) ~Compiled research data and created investor presentations in efforts to raise nearly $3.5 Million ~Teamed with company President to complete a federal grant application for the Qualifying Therapeutic Discovery Project, which was awarded $250,000 ~Received clinical trial monitor training from Trial Runners with a focus on Ophthalmology ~Monitored a successful 18 subject Phase I clinical trial for a novel therapeutic to treat Wet Age-Related Macular Degeneration (Wet AMD) ~Compiled research data and created investor presentations in efforts to raise nearly $3.5 Million ~Teamed with company President to complete a federal grant application for the Qualifying Therapeutic Discovery Project, which was awarded $250,000